UBS Group AG - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$13,694
+55.9%
5,267
+9.2%
0.00%
Q1 2023$8,782
-86.9%
4,825
-86.1%
0.00%
Q3 2022$67,000
-23.9%
34,809
+18.7%
0.00%
Q2 2022$88,000
-26.7%
29,336
-7.4%
0.00%
Q1 2022$120,000
-69.5%
31,681
-8.5%
0.00%
Q4 2021$394,000
+5528.6%
34,611
+8160.4%
0.00%
Q3 2021$7,000
-30.0%
419
-6.9%
0.00%
Q2 2021$10,0004500.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,474,572$9,329,0007.10%
Novo Holdings A/S 4,840,413$18,248,0000.96%
RA Capital Management 3,350,506$12,631,0000.28%
Avidity Partners Management LP 1,850,000$6,975,0000.14%
ACT CAPITAL MANAGEMENT, LLC 15,000$57,0000.06%
Baker Brothers Advisors 812,640$3,064,0000.02%
CAAS CAPITAL MANAGEMENT LP 105,091$396,0000.02%
Evercore Wealth Management, LLC 146,676$553,0000.01%
Jump Financial, LLC 21,300$80,0000.00%
JANUS HENDERSON GROUP PLC 1,719,610$6,486,0000.00%
View complete list of CYTEIR THERAPEUTICS INC shareholders